MedTrace Logo

Observational Multicenter Non-interventional Study on COPD Patients Treatment Strategies at the Time of Hospital Discharge and Within 12 Months of Follow-up on an Outpatient Primary Care Basement

NCT02346292 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1250

Last updated 2017-12-22

No results posted yet for this study

Summary

The study is an observational multicenter descriptive study. It is planned to enroll approximately 1250 subjects with severe and very severe COPD hospitalized for the reason of COPD exacerbation into departments of pulmonology or therapy. The study will be conducted in approximately 20-25 institutions of treatment and prevention in Russian Federation and will include about 50 to 60 subject at each clinical site.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Alexander Bedenkov, Medical Director · AstraZeneca

  • Sergey Avdeev, MD, PHD · Federal State Institution "Scientific Research Institute of Pulmonology" FMBA of Russia

  • Andrey Belevsky, PHD · Federal State Institution "Scientific Research Institute of Pulmonology" FMBA of Russia

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2016-12-30
Completion
2016-12-30

Countries

  • Russia

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02346292 on ClinicalTrials.gov